covid-19 recommendations patient

WHO recommends against the use of convalescent plasma to treat COVID-19

Reading now: 879
www.who.int

Trials for severe and critical patients should continueWHO has updated its living guideline on COVID-19 therapeutics to include convalescent plasma.

For non-severe COVID-19 patients, WHO recommends against its use, while it should only be used within clinical trials for severe and critical COVID-19 patients.Convalescent plasma is a transfusion of blood plasma from someone who has recovered from COVID-19.Current evidence shows that convalescent plasma does not improve survival or reduce the need for mechanical ventilation, while it has significant costs.

An independent panel of experts, the guidelines development group, looked at pooled data from 16 randomized controlled trials, including 16 236 patients with non-severe, severe, and critical

Read more on who.int
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA